Nancy Bunin
Overview
Explore the profile of Nancy Bunin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dvorak C, Long-Boyle J, Holbrook-Brown L, Abdel-Azim H, Bertaina A, Vatsayan A, et al.
Blood Adv
. 2024 Jul;
8(23):6003-6014.
PMID: 39042892
We hypothesized that the inferior disease-free survival (DFS) seen in older patients who underwent αβ-T-cell/CD19-depleted (AB-TCD) haploidentical hematopoietic cell transplantation (HCT) for hematologic malignancies is caused by excessive exposure to...
2.
Nikiforow S, Whangbo J, Reshef R, Tsai D, Bunin N, Abu-Arja R, et al.
Blood Adv
. 2024 Apr;
8(12):3001-3012.
PMID: 38625984
Patients with Epstein-Barr virus (EBV)-positive posttransplant lymphoproliferative disease (EBV+ PTLD) in whom initial treatment fails have few options and historically low median overall survival (OS) of 0.7 months after allogeneic...
3.
Elgarten C, Wohlschlaeger A, Levy E, Tadley K, Wang L, Atkinson M, et al.
Transplant Cell Ther
. 2023 Jul;
29(10):635.e1-635.e8.
PMID: 37517611
Revaccination after hematopoietic cell transplantation (HCT) is critical to prevent morbidity and mortality from vaccine-preventable illnesses. The global aim of our quality improvement initiative was to enhance timely, correct, and...
4.
Chu Y, Milner J, Lamb M, Maryamchik E, Rigot O, Ayello J, et al.
J Infect Dis
. 2022 Dec;
227(6):788-799.
PMID: 36583990
Background: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus-specific cytotoxic T-cell lymphocytes (vCTLs) could provide a promising modality in COVID-19 treatment. We...
5.
Leahy A, Li Y, Talano J, Elgarten C, Seif A, Wang Y, et al.
Blood Adv
. 2021 Dec;
6(4):1175-1185.
PMID: 34872106
Unrelated donor (URD) hematopoietic stem cell transplant (HSCT) is associated with an increased risk of severe graft-versus-host disease (GVHD). TCRαβ/CD19 depletion may reduce this risk, whereas maintaining graft-versus-leukemia. Outcome data...
6.
Chiesa R, Boelens J, Duncan C, Kuhl J, Sevin C, Kapoor N, et al.
Blood Adv
. 2021 Nov;
6(5):1512-1524.
PMID: 34781360
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in early cerebral adrenoleukodystrophy can stabilize neurologic function and improve survival but has associated risks including transplant-related mortality (TRM), graft failure, and graft-versus-host disease...
7.
Davidow K, Bunin N, Goldfarb S, Li Y, Freedman J
J Pediatr Hematol Oncol
. 2021 Sep;
44(6):e926-e929.
PMID: 34486541
Autologous hematopoietic stem cell transplant (ASCT) may be curative therapy for pediatric patients with relapsed/refractory Hodgkin lymphoma (HL). Therapy for HL may involve pulmonary toxic modalities. Little information exists regarding...
8.
Sun D, Le Coz C, Bunin N, Romberg N
J Clin Immunol
. 2021 Jun;
41(7):1668-1670.
PMID: 34159508
No abstract available.
9.
Patel T, Henrickson S, Moser E, Field N, Maurer K, Dawany N, et al.
J Allergy Clin Immunol Pract
. 2021 Apr;
9(7):2885-2893.e3.
PMID: 33894394
Background: Mutations in ITCH, which encodes an E3 ubiquitin-protein ligase, can result in systemic autoimmunity and immunodeficiency. The clinical phenotype and mechanism of disease have not been fully characterized, resulting...
10.
Triebwasser M, Barrett D, Bassiri H, Bunin N, Elgarten C, Freedman J, et al.
Pediatr Blood Cancer
. 2021 Mar;
68(7):e29026.
PMID: 33754483
No abstract available.